Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Papulopustular Rosacea (PPR): early-phase trial registry
1 of 1 indexed Papulopustular Rosacea (PPR) trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #11,370 of 28,707 conditions by registered trial count.
1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count
Papulopustular Rosacea (PPR): 1 US clinical trial tracked, 1 recruiting.
Papulopustular Rosacea (PPR) is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Narrows Institute for Biomedical Research, running 1 of these trials.
Enrollment posture brief
Registry condition papulopustular-rosacea-ppr
OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Papulopustular Rosacea (PPR) lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Papulopustular Rosacea (PPR) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Papulopustular Rosacea (PPR) is recruiting above its size-band peers.
1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
1 total, page 1 of 1
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Papulopustular Rosacea (PPR) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Papulopustular Rosacea (PPR) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Papulopustular Rosacea (PPR) page
1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Papulopustular Rosacea (PPR) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Narrows Institute for Biomedical Research sponsors the most Papulopustular Rosacea (PPR) trials on record, review their full trial history before evaluating a specific study. See Narrows Institute for Biomedical Research's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Papulopustular Rosacea (PPR) condition card totals 1 registered trials; most-linked intervention Clascoterone Cream 1%; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.